South African thoracic society statement on obstructive airways disease and COVID-19

Abstract

• Asthmatics do not appear to have increased susceptibility to COVID-19. • Uncontrolled severe asthma may be associated with worsened COVID-19 outcomes, especially in asthmatics managed with oral corticosteroids. • Risk mitigation measures such as hand hygiene, social distancing and wearing of face masks must be observed at all times. • Asthma should be managed as outlined in local and international guidelines. • Ensure an adequate supply of medication, and inhaled corticosteroids should not be withdrawn. • Chronic obstructive pulmonary disease (COPD) is associated with severe COVID-19 disease and poor outcomes. • Maintenance of background medication is important to avoid exacerbations of COPD. • Vaccination against influenza is strongly advised for all patients with asthma and COPD. • Vaccination against pneumococcal infection is advisable for patients with COPD. • Patients with obstructive airway disease on oral corticosteroids and/or with impaired lung function should take stringent safety precautions This statement will be updated when more data become available. Asthma and COPD occur commonly in South Africa. SARS-CoV-2 is a novel coronavirus, which can result in COVID-19-associated severe respiratory infection with respiratory failure and the need for mechanical ventilation. The South African Thoracic Society has prepared a guidance statement to assist clinicians and patients with asthma and COPD during the current epidemic.